DAT1 VNTR variant
Evidence from:
primary |
all sources
Related entities (4)
| Subject | Relation | Object | p-value | Evidence |
|---|---|---|---|---|
| DAT1 VNTR | interacts_with | naltrexone | — | 1 |
| DAT1 VNTR | associated_with | nicotine | — | 1 |
| DAT1 VNTR | associated_with | smoking behavior | — | 1 |
| DRD4 VNTR | interacts_with | DAT1 VNTR | — | 1 |
Mentioned in (7)
Papers in which this entity is mentioned.
- Nanopore sequencing with unique molecular identifiers enables accurate mutation analysis and haplotyping in the complex lipoprotein(a) KIV-2 VNTR. (2024)
- Review: Pharmacogenetics of alcoholism treatment: Implications of ethnic diversity. (2017)
- Pharmacogenetics of OPRM1. (2014)
- A comparative phenotypic and genomic analysis of C57BL/6J and C57BL/6N mouse strains. (2013)
- Pharmacogenetics of smoking cessation: role of nicotine target and metabolism genes. (2012)
- Association between dopaminergic polymorphisms and borderline personality traits among at-risk young adults and psychiatric inpatients. (2010)
- Nucleotide-resolution analysis of structural variants using BreakSeq and a breakpoint library. (2010)
Merged raw entities (4)
All extracted name/type variants the normalize job merged into this entity. Use this to spot wrong merges, or aliases that should be split off.
| Raw name | Type | Papers | Mentions |
|---|---|---|---|
| vntr | variant | 4 | 8 |
| dat1 vntr | variant | 3 | 3 |
| dat1 variable number tandem repeat | variant | — | — |
| vntr in dat1 | variant | — | — |